Medical Treatment for Renal Colic and Stone Expulsion

European Urology, Supplements

Volumn 10, Issue 5, 2011, Pages 415-422

  Kallidonis, Panagiotis ^a   Liourdi, Despoina ^a   Liatsikos, Evangelos ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Alfuzosin; Desmopressin; Diclofenac; ESWL; Expulsion; Ketorolac; Nifedipine; Opioids; Phosphodiesterase inhibitor; Renal colic; Stone; Tamsulosin; Ureteral stone; Vardenafil

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOTRANSFERASE; ANALGESIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; CODEINE; CORTICOSTEROID; CYCLIC AMP; CYCLIC GMP; CYCLOOXYGENASE 2 INHIBITOR; DESMOPRESSIN; DICLOFENAC; DIPYRONE; IBUPROFEN; KETOROLAC; MORPHINE; MORPHINE SULFATE; MUSCARINIC RECEPTOR BLOCKING AGENT; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PETHIDINE; PHOSPHODIESTERASE; ROFECOXIB; ROWATINEX; TAMSULOSIN; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL PAIN; ANALGESIA; ANAPHYLAXIS; BILIARY SPASM; BILIARY TRACT DISEASE; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CONSERVATIVE TREATMENT; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DECOMPRESSION SURGERY; DIARRHEA; DISORIENTATION; DIZZINESS; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DYSPEPSIA; DYSPHORIA; EPIGASTRIC PAIN; EPISTAXIS; ESOPHAGITIS; FATIGUE; FLUSHING; GASTROINTESTINAL HEMORRHAGE; HEMOLYSIS; HUMAN; HYPERTENSION; HYPONATREMIA; HYPOTENSION; INJECTION SITE PAIN; INTRACRANIAL PRESSURE; KIDNEY COLIC; KIDNEY FUNCTION; LOADING DRUG DOSE; MIOSIS; MUSCLE SPASM; NAUSEA; NONHUMAN; PAIN ASSESSMENT; PARALYTIC ILEUS; PERCUTANEOUS NEPHROSTOMY; PERIPHERAL EDEMA; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESTLESSNESS; REVIEW; RHINITIS; SEDATION; SEIZURE; SIDE EFFECT; STENT; THROMBOCYTOPENIA; THROMBOSIS; TINNITUS; TOXIC MEGACOLON; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URETER STONE; URINE RETENTION; UROLITHIASIS; VOMITING; WATER INTOXICATION; XEROSTOMIA;

EID: 80052180662     PISSN: 15699056     EISSN: 18781500     Source Type: Journal    
DOI: 10.1016/j.eursup.2011.07.003     Document Type: Review

References (52)

1. Bihl G., Meyers A. Recurrent renal stone disease-advances in pathogenesis and clinical management. Lancet 2001, 358:651-656.
2. Masarani M., Dinneen M. Ureteric colic: new trends in diagnosis and treatment. Postgrad Med J 2007, 83:469-472.
3. Seitz C., Liatsikos E., Porpiglia F., Tiselius H.-G., Zwergel U. Medical therapy to facilitate the passage of stones: what is the evidence?. Eur Urol 2009, 56:455-471.
4. Tiselius H.G., Aronsen T., Bohgard S., et al. Is high diuresis an important prerequisite for successful SWL-disintegration of ureteral stones?. Urol Res 2010, 38:143-146.
5. Marston W.A., Ahlquist R., Johnson G., Meyer A.A. Misdiagnosis of ruptured abdominal aortic aneurysms. J Vasc Surg 1992, 16:17-22.
6. Preminger G.M., Tiselius H.-G., Assimos D.G., et al. From the American Urological Association Education and Research, Inc., and the European Association of Urology. 2007 Guideline for the management of ureteral calculi. Eur Urol 2007, 52:1610-1631.
7. Heid F., Jage J. The treatment of pain in urology. BJU Int 2002, 90:481-488.
8. Sahin A., Erdemli I., Bakkaloglu M., Ergen A., Basar I., Remzi D. The effect of nifedipine and verapamil on rhythmic contractions of human isolated ureter. Arch Int Physiol Biochim Biophys 1993, 101:245-247.
9. Sigala S., Dellabella M., Milanese G., et al. Evidence for the presence of a1 adrenoceptor subtypes in the human ureter. Neurourol Urodynam 2005, 24:142-148.
10. Itoh Y., Kojima Y., Yasui T., Tozawa K., Sasaki S., Kohri K. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 2007, 14:749-753.
11. Uberti M.A., Hall R.A., Minneman K.P. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 2003, 64:1379-1390.
12. Stief C.G., Taher A., Truss M., et al. Phosphodiesterase isoenzymes in human ureteral smooth muscle: identification, characterization, and functional effects of various phosphodiesterase in vitro. Urol Int 1995, 55:183-189.
13. Mastrangelo D., Wisard M., Rohner S., Leisinger H., Iselin C.E. Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, decrease agonist induced contractions of the pig isolated ureter. Urol Res 2000, 28:376-382.
14. Laerum E., Ommundsen O.E., Granseth J.E., Christiansen A., Fagertun H.E. Oral diclofenac in the prophylactic treatment of recurrent renal colic: a double-blind comparison with placebo. Eur Urol 1995, 28:108-111.
15. Phillips E., Hinck B., Pedro R. Celecoxib in the management of acute renal colic: a randomized controlled clinical trial. Urology 2009, 74:994-999.
16. Djaladat H., Mahouri K., Khalifeh Shooshtary F., Ahmadieh A. Effect of Rowatinex on calculus clearance after extracorporeal shock wave lithotripsy. Urol J 2009, 6:9-13.
17. Romics I., Siller G., Kohnen R., Mavrogenis S., Varga J., Holman E. A special terpene combination (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial. Urol Int 2011, 86:102-109.
18. Aldemir M., Ucgul J.E., Kayigil O. Evaluation of the efficiency of tamsulosin and rowanitex in patients with distal ureteral stones: a prospective, randomized, controlled study. Int Urol Nephrol 2011, 43:79-83.
19. Schneider T., Fetscher C., Krege S., Michel M.C. Signal transduction underlying carbachol-induced contraction of human urinary bladder. J Phramacol Exp Ther 2004, 309:1148-1153.
20. Holdgate A., Pollock T. Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ 2004, 328:1401.
21. Zwergel U., Felgner J., Rombach H., Zwergel T. Aktuelle conservative Behandlung einer Nierenkolik: Stellenwert der Prostaglandinsynthesehemmer. Der Schmerz 1998, 12:112-117.
22. Edwards J.E., Meseguer F., Faura C., Moore R.A., McQuay H.J. Single dose dipyrone for acute renal colic pain. Cochrane Database Syst Rev 2002, CD00386.
23. Erturhan S., Erbagci A., Yagci F., Celik M., Solakhan M., Sarica K. Comparative evaluation of efficacy of use of tamsulosin and/or tolterodine for medical treatment of distal ureteral stones. Urology 2007, 69:633-636.
24. Salehi M., Fouladi Mehr M., Shiery H., et al. Does methylprednisolone acetate increase the success rate of medical therapy for passing distal ureteral stones [abstract 92]?. Eur Urol Suppl 2005, 4(3):25.
25. Seitz C. Medical expulsive therapy of ureteral calculi and supportive therapy after extracorporeal shock wave lithotripsy. Eur Urol Suppl 2010, 9:807-813.
26. Pedro R.N., Hinck B., Hendlin K., Feia K., Canales B.K., Monga M. Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol 2008, 179:2244-2247. discussion 2247.
27. Kobayashi M., Naya Y., Kino M., et al. Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone. Int J Urol 2008, 15:495-498.
28. Sun X., He L., Ge W., Lv J. Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. J Urol 2009, 181:1716-1720.
29. Ohgaki K., Horiuchi K., Hikima N., Kondo Y. Facilitation of expulsion of ureteral stones by addition of α1-blockers to conservative therapy. Scand J Urol Nephrol 2010, 44:420-424.
30. Porpiglia F., Destefanis P., Fiori C., Scarpa R.M., Fontana D. Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. Urology 2002, 59:835-838.
31. Borghi L., Meschi T., Amato F., et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, doubleblind, placebo-controlled study. J Urol 1994, 152:1095-1098.
32. Porpiglia F., Destefanis P., Fiori C., Fontana D. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 2000, 56:579-582.
33. Dellabella M., Milanese G., Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 2005, 174:167-172.
34. Singh S.K., Agarwal M.M., Sharma S. Medical therapy for calculus disease. BJU Int 2011, 107:356-368.
35. Safdar B., Degutis L.C., Landry K., Vedere S.R., Moscovitz H.C., D'Onofrio G. Intravenous morphine plus ketorolac is superior to either drug alone for treatment of acute renal colic. Ann Emerg Med 2006, 48:173-181. 181.e1.
36. Brater D.C. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am J Med 1999, 107:65-70.
37. Gillis J.G., Brogden R.N. Ketorolac: a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 1997, 53:139-188.
38. Snir N., Moskovitz B., Nativ O., et al. Papaverine hydrochloride for the treatment of renal colic: an old drug revisited. A prospective, randomized study. J Urol 2008, 179:1411-1414.
39. Roshani A., Falahatkar S., Khosropanah I., et al. Assessment of clinical efficacy of intranasal desmopressin spray and diclofenac sodium suppository in treatment of renal colic versus diclofenac sodium alone. Urology 2010, 75:540-542.
40. Mortelmans L.J., Desruelles D., Baert J.A., Hente K.R., Tailly G.G. Use of tramadol drip in controlling renal colic pain. J Endourol 2006, 20:1010-1015.
41. Hazhir S., Badr Y.A., Darabi J.N. Comparison of intranasal desmopressin and intramuscular tramadol versus pethidine in patients with renal colic. Urol J 2010, 7:148-151.
42. Djaladat H., Tajik P., Fard S.A., Alehashemi S. The effect of aminophylline on renal colic: a randomized double blind controlled trial. South Med J 2007, 100:1081-1084.
43. Hermanns T., Sauermann P., Rufibach K., Frauenfelder T., Sulser T., Strebel R.T. Is there a role for tamsulosin in the treatment of distal ureteral stones of 7mm or less? Results of a randomised, doubleblind, placebo-controlled trial. Eur Urol 2009, 56:407-412.
44. Micali S., GrandeM, Sighinolfi M.C., De Stefani S., Bianchi G. Efficacy of expulsive therapy using nifedipine or tamsulosin, both associated with ketoprofene, after shock wave lithotripsy of ureteral stones. Urol Res 2007, 35:133-137.
45. Liatsikos E.N., Katsakiori P.F., Assimakopoulos K., et al. Doxazosin for the management of distal-ureteral stones. J Endourol 2007, 21:538-541.
46. Cooper J.T., Stack G.M., Cooper T.P. Intensive medical management of ureteral calculi. Urology 2000, 56:575-578.
47. Gravina G.L., Costa A.M., Ronchi P. Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 2005, 66:24-28.
48. Keshvary M., Taghavi R., Arab D. The effect of tamsulosin and nifedipine in facilitating juxtavesical stones' passage. Med J Mashhad University Med Sci 2006, 48:425-430.
49. Porpiglia F., Ghignone G., Fiori C., Fontana D., Scarpa R.M. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 2004, 172:568-571.
50. Han M.C., Jeong W.S., Shim B.S. Additive expulsion effect of tamsulosin after shock wave lithotripsy for upper ureteral stones. Korean J Urol 2006, 47:813-817.
51. Dellabella M., Milanese G., Muzzonigro G. Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. Urology 2005, 66:712-715.
52. Bensalah K., Pearle M., Lotan Y. Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol 2008, 53:411-419.